Stonepine Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Sell |
|
|||||
|
2025
Q1 | $24.3K | Sell |
|
|||||
|
2024
Q4 | $21.3M | Sell |
|
|||||
|
2024
Q3 | $37.4M | Hold |
|
|||||
|
2024
Q2 | $20.9M | Sell |
|
|||||
|
2024
Q1 | $22.6M | Sell |
|
|||||
|
2023
Q4 | $41.7M | Buy |
|
|||||
|
2023
Q3 | $32.6M | Buy |
|
|||||
|
2023
Q2 | $32.4M | Buy |
|
|||||
|
2023
Q1 | $25.4M | Buy |
|
|||||
|
2022
Q4 | $26.9M | Buy |
|
|||||
|
2022
Q3 | $12.2M | Sell |
|
|||||
|
2022
Q2 | $13.9M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Sell |
|
|||||
|
2021
Q4 | $14M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $3.75M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $217K | Buy |
|